Exemptia
Find prospects like Exemptia
Get a list of similar companies, matched by industry, size and location, ready for outreach.
Free sample of 25 companies by email within one business day. No spam: we only use your email for this request.
About Exemptia
Adalimumab, trade name Exemptia, is a potent TNF-inhibitor and anti-inflammatory drug manufactured and promoted by Zydus Cadila in India. Adalimumab Biosimilar Dosage is prescribed to people who have Psoriatic and Rheumatoid Arthritis.
Its primary NAICS classification is 325412 (Pharmaceutical Preparation Manufacturing).
Business Contact Information
- Website
- exemptia.com
- facebook.com/exemptiacare
- Address
- United States
Industry & Classification
NAICS Codes
- 32
- 3254Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
SIC Codes
- 28Chemicals And Allied Products
- 283Drugs
- 2834Pharmaceutical Preparation Mfg.
Company Details
- Employees
- 21 (21-50)
- Annual Revenue
- $4.4M ($1M-$5M)
Exemptia: frequently asked questions
What does Exemptia do?
Adalimumab, trade name Exemptia, is a potent TNF-inhibitor and anti-inflammatory drug manufactured and promoted by Zydus Cadila in India. Adalimumab Biosimilar Dosage is prescribed to people who have Psoriatic and Rheumatoid Arthritis.
How many employees does Exemptia have?
Exemptia has about 21 employees (the 21-50 range).
What is Exemptia's annual revenue?
Exemptia's annual revenue is estimated at $4.4M (the $1M-$5M range).
What industry is Exemptia in?
Exemptia's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
How can I contact Exemptia?
Its website is exemptia.com.
Largest companies on Factur
Own this business?
Keep your profile accurate — or ask us to take it down. We acknowledge requests within 7 days and resolve them within 30 days.
Prefer email? privacy@facturmfg.com
Add this badge to your website — show visitors you're listed on Factur Data.